top of page


Viralgen Vector Core S.L.

Viralgen Vector Core becomes the convergence point from experienced specialized organizations in biotechnology and life science fields, united with the aim of creating a CDMO in the sector of gene therapy and innovative medicines. Developing and manufacturing in order to contribute to the progress in health and welfare of people.

One of the key aspects for this exclusive technology to reach patients is the cGMP production for rAAV manufacturing in large batches. Askbio has been working in the field of gene therapy for more than 15 years and has developed its own cell line and manufacturing system. This allows large cGMP manufacturing of rAAV vectors with superior yield to others in the market.

bottom of page